TRPV1 and asthma: Thus, virus-induced rise in intracellular Ca2+ mediated by TRPV1 activation might contribute to the clinical manifestations of asthma, including augmented synthesis and release of TH2 cytokines, mucus overproduction, breakdown in barrier permeability, and increased bronchoconstriction.